Ikena Oncology, Inc.
IKNA
$1.25
$0.032.46%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/21/2025
-
MarketBeat
4/20/2025
-
Ticker Report
4/20/2025
-
MarketBeat
3/28/2025
-
Globe Newswire
3/8/2025
-
MarketBeat
3/7/2025
-
MarketBeat
3/7/2025
-
TipRanks Financial Blog
3/7/2025
-
TipRanks Financial Blog
3/4/2025
-
MarketBeat
3/4/2025
-
MarketBeat
2/19/2025
-
MarketBeat
2/15/2025
-
GuruFocus
2/15/2025
-
GuruFocus
2/8/2025
-
MarketBeat
1/16/2025
-
Ticker Report
12/30/2024
-
Zacks Investment Research
12/29/2024
-
TipRanks Financial Blog
12/25/2024
-
Ticker Report
12/24/2024
-
MarketBeat
12/23/2024
-
GuruFocus
12/23/2024
-
The Fly
12/23/2024
-
Seeking Alpha - Healthcare
12/23/2024
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 6, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
857 273 8343
Address
645 Summer Street
Boston, MA 02210
Boston, MA 02210
Country
Year Founded
Business Description
Sector
Ikena Oncology, Inc., an oncology company, focuses on developing therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance. It develops IK-595, a...
more